Dr. Anne Wagner and a team of researchers at Remedy Institute in Toronto, Canada are conducting a treatment development study of MDMA-assisted cognitive processing therapy (CPT) for individuals with posttraumatic stress disorder (PTSD). This investigator-initiated trial is currently recruiting and is expected to start in November of 2021. Visit the official study page on clinicaltrials.gov to learn more.
Investigator-Initiated Trials Recruitment: A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for PTSD
